Eaton Vance Tax-Managed Buy-Write Strategy Fund
Change company Symbol lookup
Select an option...
EXD Eaton Vance Tax-Managed Buy-Write Strategy Fund
ADVM Adverum Biotechnologies Inc
JRO Nuveen Floating Rate Income Opportunity Fund
SND Smart Sand Inc
EMR Emerson Electric Co
ZM Zoom Video Communications Inc
CYCN Cyclerion Therapeutics Inc
FRCGF Faircourt Gold Income Corp
BAC-O Bank of America Corp
AFT Apollo Senior Floating Rate Fund
Go

Company profile

Eaton Vance Tax-Managed Buy-Write Strategy Fund (the Fund) is a diversified, closed-end management investment company. The Fund’s primary investment objective is to provide income and gains, with a secondary objective of capital appreciation. Its strategy consists of owning a diversified portfolio of common stocks and selling covered index call options (a buy-write strategy). The Fund invests at least 80% of its total assets in a diversified portfolio of common stocks. Eaton Vance Management(EVM) is the investment adviser of the Fund. EVM has engaged its affiliate, Parametric Portfolio Associates LLC , as the sub-adviser of the Fund.

Price
Delayed
$11.53
Day's Change
0.095 (0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
11.80
Day's Low
11.51
Volume
(Light)

Today's volume of 30,171 shares is on pace to be much lighter than EXD's 10-day average volume of 52,323 shares.

30,171

DexCom Inc. Stock Rises Friday, Outperforms Market

4:50 pm ET October 29, 2021 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of DexCom Inc. (DXCM) rose 9.27% to $623.21 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.19% to 4,605.38 and the Dow Jones Industrial Average rising 0.25% to 35,819.56. This was the stock's second consecutive day of gains. DexCom Inc. hit a new 52-week high, surpassing its previous peak of $579.00, which the company reached on September 23rd.

The stock outperformed some of its competitors Friday, as Johnson & Johnson (JNJ) rose 0.02% to $162.88, Abbott Laboratories (ABT) rose 0.92% to $128.89, and Medtronic PLC (MDT) fell 1.16% to $119.86. Trading volume (1.3 M) eclipsed its 50-day average volume of 482,101.

Data source: Dow Jones Market Data, FactSet. Data compiled October 29, 2021.

-MarketWatch Automation

	

(END) Dow Jones Newswires

October 29, 2021 16:50 ET (20:50 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.